Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Creative Life Science CoROCO:7837 +0.41%20 Return-on-Tangible-Asset is 11.18% as of Dec. 2025, which is 21% above its 10-year median of 9.27. GuruFocus rates ROCO:7837 with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 1,415 Biotechnology companies, Creative Life Science Co ranks better than 90.95% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Creative Life Science Co's annualizedNet Income for the quarter that ended in Dec. 2025 was NT$142 Mil. Creative Life Science Co's average total tangible assets for the quarter that ended in Dec. 2025 was NT$1,273 Mil. Therefore, Creative Life Science Co's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 11.18%.
The historical rank and industry rank for Creative Life Science Co's Return-on-Tangible-Asset or its related term are showing as below:
ROCO:7837'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 8.24 Med: 9.27 Max: 18.77
Current: 9.43
During the past 5 years, Creative Life Science Co's highest Return-on-Tangible-Asset was 18.77%. The lowest was 8.24%. And the median was 9.27%.
ROCO:7837's Return-on-Tangible-Asset is ranked better than 90.95% of 1415
companies
in the Biotechnology industry
Industry Median: -36.15
vs ROCO:7837: 9.43
Creative Life Science Co (ROCO:7837) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Creative Life Science Co Return-on-Tangible-Asset Related Terms
Creative Life Science Co Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Creative Life Science Co's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creative Life Science Co Return-on-Tangible-Asset Chart
ROCO:7837 vs VRTX, REGN, RVMD: Return-on-Tangible-Asset Comparison
For the Biotechnology subindustry, Creative Life Science Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creative Life Science Co Return-on-Tangible-Asset vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Creative Life Science Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Creative Life Science Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 11.18% mean?
Creative Life Science Co (ROCO:7837) has a Return-on-Tangible-Asset of 11.18% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Creative Life Science Co and its competitors. This is 21% above median its historical median of 9.27. Over the past decade, Creative Life Science Co's Return-on-Tangible-Asset has ranged from 8.24 to 18.77. According to the industry distribution chart, Creative Life Science Co ranks #128 out of 1415 companies in the Biotechnology industry, placing it in the top 9%.
Is Creative Life Science Co's Return-on-Tangible-Asset too high?
Creative Life Science Co's current Return-on-Tangible-Asset of 11.18% is 21% above median its 10-year median of 9.27. Over the past 10 years, this metric has ranged from a low of 8.24 to a high of 18.77. Based on the distribution chart, Creative Life Science Co ranks #128 out of 1415 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Creative Life Science Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Creative Life Science Co's Return-on-Tangible-Asset compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Creative Life Science Co ranks #128 out of 1415 companies for Return-on-Tangible-Asset. This places Creative Life Science Co in the top 9% of its industry — outperforming the majority of peers. Historically, Creative Life Science Co's own Return-on-Tangible-Asset has ranged from 8.24 to 18.77 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Biotechnology company?
A good Return-on-Tangible-Asset depends on the Biotechnology industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Creative Life Science Co and its competitors. Creative Life Science Co's current Return-on-Tangible-Asset is 11.18%, which is 21% above median its own 10-year median of 9.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Life Science Co stock overvalued right now?
Creative Life Science Co (ROCO:7837) has a current Return-on-Tangible-Asset of 11.18%. The current Return-on-Tangible-Asset is 11.18%, which is 21% above median its 10-year median of 9.27. Creative Life Science Co's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Creative Life Science Co (ROCO:7837), the current Return-on-Tangible-Asset is 11.18% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Creative Life Science Co Ltd is engaged in providing products of microbiology, and it has prepared media products and diagnostic reagents. The main products of CMP (Creative Media Plate) are solid and liquid media, which can be used for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. Its product line is Transport Medium, Prepared Tube Media, Prepared Plated Media, VTM & I-VTM, Bacterial strain preservation system, and CMP SteriPack triple wrapped media.
20GF Score
Get the complete analysis for ROCO:7837
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7837 has been successfully added to your 
